Cytoplasmic lipid bodies in eosinophils: Central roles in eicosanoid generation

Allergology International

Volumn 46, Issue 3, 1997, Pages 141-153

  Weller, Peter F ^a   Bozza, Patricia T ^a   Yu, Wengui ^a   Dvorak, Ann M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

aspirin; cyclooxygenase; eosinophils; leukotrienes; lipid bodies; lipoxygenase; platelet activating factor

Indexed keywords

EID: 85010134012     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.46.141     Document Type: Review

References (75)

1. 3H]-arachidonic acid incorporated by mast cells, macrophages and other cell types. In: Bailey JM (ed.). Prostaglandins, leukotrienes, and lipoxins. New York: Plenum Publishing Co., 1985; 221–39.
2. Brown, MS, Ho, YK, Goldstein, JL. The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. J. Biol. Chem. 1980; 255: 9344–52.
3. Weller, PF, Dvorak, AM. Arachidonic acid incorporation by cytoplasmic lipid bodies of human eosinophils. Blood 1985; 65: 1269–74.
4. Weller, PF, Ackerman, SJ, Nicholson-Weller, A, Dvorak, AM. Cytoplasmic lipid bodies of human neutrophilic leukocytes. Am. J. Pathol. 1989; 135: 947–59.
5. Coimbra, A, Lopes-Vaz, A. The presence of lipid droplets and the absence of stable sudanophilia in osmium-fixed human leukocytes. J. Histochem. Cytochem. 1971; 19: 551–7.
6. Robinson, JM, Karnovsky, ML, Karnovsky, MJ. Glycogen accumulation in polymorphonuclear leukocytes, and other intracellular alterations that occur during inflammation. J. Cell Biol. 1982; 95: 933–42.
7. Triggiani, M, Oriente, A, Seeds, MC, Bass, DA, Marone, G, Chilton, FH. Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. J. Exp. Med. 1995; 182: 1181–90.
8. Sonek, J, Gabbe, SG, Lams, JD, Kniss, DA. Morphologic changes in the human amnion epithelium that accompany labor as seen with scanning and transmission electron microscopy. Am. J. Obstet. Gynecol. 1991; 164: 11 74–80.
9. Needleman, P Turk, J, Jakschik, BA, Morrison, AR, Lefkowith, JB. Arachidonic acid metabolism. Annu. Rev. Biochem. 1986; 55: 69–102.
10. Serhan, CN. Eicosanoids in leukocyte function. Curr. Opin. Hematol. 1994; 1: 69–77.
11. Samuelsson, B, Dahlen, SE, Lindgren, JA, Rouzer, CA, Serhan, CN. Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 1987; 237: 1171–6.
12. Piomelli, D. Arachidonic acid in cell signaling. Curr. Opin. Cell Biol. 1993; 5: 274–80.
13. Henderson, WR Jr. The role of leukotrienes in inflammation. Ann. Intern. Med. 1994; 121: 684–97.
14. Xie, W, Chipman, JG, Robertson, DL, Erikson, RL, Simmons, DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl Acad. Sci. USA 1991; 88: 2692–6.
15. Fletcher, BS, Kujubu, DA, Perrin, DM, Herschman, HR. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J. Biol. Chem. 1992; 267: 4338–44.
16. Smith, WL, Meade, EA, DeWitt, DL. Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2. Ann. N.Y.Acad. Sci. 1994; 714: 136–42.
17. Irvine, RF. How is the level of free arachidonic acid controlled in mammalian cells? Biochem. J. 1982; 204: 3–16.
18. Chilton, FH, Murphy, RC. Remodeling of arachidonate-containing phosphoglycerides within the human neutrophil. J. Biol. Chem. 1986; 261: 7771–7.
19. Kroner, EE, Peskar, BA, Fischer, H, Ferber, E. Control of arachidonic acid accumulation in bone marrow-derived macrophages by acyltransferases. J. Biol. Chem. 1981; 256: 3690–7.
20. 2enzymes. Proc. Natl Acad. Sci. USA 1994; 91: 11060–4.
21. 2. J. Biol. Chem. 1994; 269: 13057–60.
22. 2. Adv. Second Messenger Phosphoprotein Res. 1993; 28: 81–9.
23. 2. J. Biol. Chem. 1994; 269: 19 480–7.
24. 2is phosphorylated and activated by MAP kinase. Cell 1993; 72: 269–78.
25. 2with membrane in the macrophage cell line RAW 264.7. J. Biol. Chem. 1990; 265: 5409–13.
26. Morita, I, Schindler, M, Regier, MK et al. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J. Biol. Chem. 1995; 270: 10 902–8.
27. 2synthase-1. Nature 1994; 367: 243–9.
28. Reddy, ST, Herschman, HR. Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J. Biol. Chem. 1994; 269: 15 473–80.
29. Lee, SH, Soyoola, E, Chanmugam, P et al. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 1992; 267: 25 934–8.
30. Rouzer, CA, Kargman, S. Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. J. Biol. Chem. 1988; 263: 10980–8.
31. Sigal, E, Grunberger, D, Craik, CS, Caughey, GH, Nadel, JA. Arachidonate 15-lipoxygenase (ω-6 lipoxygenase) from human leukocytes. Purification and structural homology to other mammalian lipoxygenases. J. Biol. Chem. 1988; 263:5328–32.
32. Rouzer, CA, Rands, E, Kargman, S, Jones, RE, Register, RB, Dixon, RA. Characterization of cloned human leukocyte 5-lipoxygenase expressed in mammalian cells. J. Biol. Chem. 1988; 263: 10135–40.
33. Rouzer, CA, Ford Hutchinson, AW, Morton, HE, Gillard, JW. MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J. Biol. Chem. 1990; 265: 1436–42.
34. Woods, JW, Evans, JF, Ethier, D et al. 5-Lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 1993; 178: 1935–46.
35. Brock, TG, Paine, RR III, Peters-Golden, M. Localization of 5-lipoxygenase to the nucleus of unstimulated rat basophilic leukemia cells. J. Biol. Chem. 1994; 269: 22 059–66.
36. 2in mouse bone marrow-derived mast cells. J. Biol. Chem. 1994; 269: 22 269–75.
37. Willingham, MC, Pastan, I. An Atlas of Immunofluorescence in Cultured Cells. New York: Academic Press, 1985.
38. Bozza, PT, Payne, JL, Morham, SG, Langenbach, R, Smithies, O, Weller, PF. Leukocyte lipid body formation and eicosanoid generation: Cyclooxygenase-independent inhibition by aspirin. Proc. Natl Acad. Sci. USA 1996; 93: 11091–6.
39. Bozza, PT, Payne, JL, Goulet, JL, Weller, PF. Mechanisms of PAF-induced lipid body formation: A central role for 5-lipoxygenase in the compartmentalization of leukocyte lipids. J. Exp. Med. 1996; 183: 1515–25.
40. Comai, K, Prose, P, Farber, SJ. Correlation of renal medullary prostaglandin content and renal interstitial cell lipid droplets. Prostaglandins 1974; 6: 375–9.
41. Dvorak, AM, Dvorak, HF, Peters, SP et al. Lipid bodies: Cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells. J. Immunol. 1983; 131: 2965–76.
42. Dvorak, AM, Hammel, I, Schulman, ES et al. Differences in the behavior of cytoplasmic granules and lipid bodies during human lung mast cell degranulation. J. Cell Biol. 1984; 99: 1678–87.
43. Weller, PF, Monahan-Earley, RA, Dvorak, HF, Dvorak, AM. Cytoplasmic lipid bodies of human eosinophils: Subcellular isolation and analysis of arachidonate incorporation. Am. J. Pathol. 1991; 138: 141–8.
44. Weller, PF, Ryeom, SW, Picard, ST, Ackerman, SJ, Dvorak, AM. Cytoplasmic lipid bodies of neutrophils: Formation induced by cis-unsaturated fatty acids and mediated by protein kinase C. J. Cell Biol. 1991; 113: 137–46.
45. 2. J. Clin. Invest. 1994; 93: 1583–91.
46. Michiels, C, Arnould, T, Knott, I, Dieu, M, Remade, J. Stimulation of prostaglandin synthesis by human endothelial cells exposed to hypoxia. Am. J. Physiol. 1993; 264: C866–74.
47. Scarfo, LM, Weller, PF, Farber, HW. Induction of cytoplasmic lipid body formation in hypoxic endothelial cells. Am. Rev. Respir. Dis. 1992; 145: A838.
48. Scarfo, LM, Weller, PF, Tzizik, DM, Farber, HW. Characteristics of cytoplasmic lipid body formation in hypoxic endothelial cells. Am. Rev. Respir. Dis. 1993; 147: A270.
49. Goulet, JL, Snouwaert, JN, Latour, AM, Coffman, TM, Koller, BH. Altered inflammatory responses in leukotriene deficient mice. Proc. Natl Acad. Sci. USA 1994; 91: 12 852–6.
50. Chen, X-S, Sheller, JR, Johnson, EN, Funk, CD. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 1994; 372: 179–82.
51. O'Flaherty, JT, Rossi, AG. 5-Hydroxyicosatetraenoate stimulates neutrophils by a stereospecific, G protein-linked mechanism. J. Biol. Chem. 1993; 268: 14 708–14.
52. Futaki, N, Takahashi, S, Yokoyama, M, Arai, I, Higuchi, S, Otomo, S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/ cyclooxygenase (Cox-2) activity in vitro. Prostaglandins 1994; 47: 55–9.
53. Bauldry, SA, Wykle, RL, Bass, DA. Phospholipase A, activation in human neutrophils. Differential actions of diacylglycerols and alkylacylglycerols in priming cells for stimulation by N-formyl-met-leu-phe. J. Biol. Chem. 1988; 263: 16 787–95.
54. Nishizuka, Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258: 607–14.
55. Agwu, DE, McPhail, LC, Chabot, MC, Daniel, LW, Wykle, RL, McCall, CE. Choline-linked phosphoglycerides. A source of phosphatidic acid and diglycerides in stimulated neutrophils. J. Biol. Chem. 1989, 264: 1405–13.
56. Dougherty, RW, Dubay, GR, Niedel, JE. Dynamics of the diradylglycerol responses of stimulated phagocytes. J Biol. Chem. 1989; 264: 11 263–9.
57. Chanmugam, P, Feng, L, Liou, S et al. Radicicol, a protein tyrosine kinase inhibitor, suppresses the expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide and in experimental glomerulonephritis. J. Biol. Chem. 1995; 270: 5418–26.
58. Rollins, TE, Smith, WL. Subcellular localization of prostaglandin-forming cyclooxygenase in Swiss mouse 3T3 fibroblasts by electron microscopic immuno-cytochemistry. J. Biol. Chem. 1980; 255: 4872–5.
59. Reiger, MK, DeWitt, DL, Schindler, MS, Smith, WL. Subcellular localization of prostaglandin endoperoxide synthase-2 in murine 3T3 cells. Arch. Biochem. Biophys. 1993; 301: 439–44.
60. Dvorak, AM, Morgan, E, Schleimer, RF, Ryeom, SW, Lichtenstein, LM, Weller, PF. Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to nonmembrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes and neutrophils. J. Histochem. Cytochem. 1992; 40: 759–69.
61. Dvorak, AM, Morgan, E, Tzizik, DM, Weller, PF. Prostaglandin endoperoxide synthase (cyclooxygenase): ultrastructural localization to nonmembrane-bound cytoplasmic lipid bodies in human eosinophils and murine 3T3 fibroblasts. Int. Arch. Allergy Immunol. 1994; 105: 245–50.
62. Dvorak, AM, Schleimer, RP, Dvorak, AM, Lichtenstein, LM, Weller, PF. Human lung mast cell and alveolar macrophage cytoplasmic lipid bodies contain arachidonic acid and prostaglandin endoperoxide synthase (cyclooxygenase), the substrate and enzyme necessary for prostaglandin production. Int. Arch. Allergy Immunol. 1992; 99: 208–17.
63. Dvorak, AM, Weller, PF, Harvey, VS, Morgan, ES, Dvorak, HF. Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to isolated, purified fractions of guinea pig peritoneal macrophages and line 10 hepatocarcinoma cells. Int. Arch. Allergy Immunol. 1993; 101: 136–42.
64. Cerletti, C, Livio, M, Doni, MG, De Gaetano, G. Salicylate fails to prevent the inhibitory effect of 5, 8, 11, 14-eicosatetraynoic acid on human platelet cyclo-oxygenase and lipoxygenase activities. Biochim. Biophys. Acta 1983; 759: 125–7.
65. Cerletti, C. Interaction of non-steroidal anti-inflammatory drugs on platelet cyclo-oxygenase and lipoxygenase activity. Inf. J. Tissue React. 1985; 7: 309–12.
66. Punnonen, K, Uotila, P The effect of aspirin on the metabolism of exogenous arachidonic acid in human polymorphonuclear leukocytes. Prostaglandins Leukot. Med. 1984; 15: 177–85.
67. Laposata, M, Kaiser, SL, Capriotti, AM. Icosanoid production can be decreased without alterations in cellular arachidonate content or enzyme activities required for arachidonate release and icosanoid synthesis. J. Biol. Chem. 1988; 263: 3266–73.
68. Schneeberger, EE, Lynch, RD, Geyer, RP Formation and disappearance of triglyceride droplets in strain L fibroblasts. Exp. Cell Res. 1971; 69: 193–206.
69. 4or its omega-metabolites. Biochem. J. 1987, 241: 55–62.
70. Lee, TH, Mencia-Huerta, J-M, Shih, C, Corey, EJ, Lewis, RA, Austen, KF. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J. Clin. Invest. 1984; 74: 1922–33.
71. 4by human neutrophils: Involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway. J. Immunol. 1987; 138: 3396–402.
72. Chang, WC, Su, GW. Stimulation of 5-lipoxygenase activity in polymorphonuclear leukocytes of rats by caseinate treatment. Biochem Pharmacol. 1987; 36: 3033–6.
73. 4production by eosinophils from asthmatic and normal subjects. Am. Rev. Resp. Dis. 1988; 138: 799–804.
74. Beil, WJ, Weller, PF, Peppercorn, MA, Dvorak, AM. Ultrastructural immunogold localization of subcellular sites of TNF-α in colonic Crohn's disease. J. Leukocyte Biol. 1995; 58: 284–98.
75. Beil, WJ, Weller, PF, Tzizik, DM, Galli, SJ, Dvorak, AM. Ultrastructural immunogold localization of tumor necrosis factor to the matrix compartment of human eosinophil secondary granules. J. Histochem. Cytochem. 1993; 41: 1611–15.